In the complex landscape of American consumer protection, few regulatory relationships are as strained as the one between pet food advocates and the U.S. Food and Drug Administration (FDA). For years, TruthaboutPetFood.com, led by consumer advocate Susan Thixton, has functioned as a watchdog, relentlessly pressing the FDA to enforce federal statutes regarding the safety, labeling, and transparency of pet food products. However, the agency’s recent pattern of behavior—characterized by prolonged silences, circular referrals, and a refusal to engage with substantive policy inquiries—has raised alarming questions about the oversight of a multi-billion-dollar industry.
At the heart of this conflict is a fundamental disagreement over the interpretation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). While the FDA explicitly states on its website that the Act requires animal foods to be "truthfully labeled," advocates argue that the agency has effectively abandoned this mandate, allowing manufacturers to use misleading imagery and vague terminology that obfuscate the true nature of the products consumers feed their pets.
The Chronology of Non-Response: A Timeline of Frustration
The relationship between advocates and the Center for Veterinary Medicine (CVM), the branch of the FDA responsible for pet food, has devolved into a cycle of inquiries met with either bureaucratic evasion or total silence.
The Meow Mix Discrepancy (January – September 2026)
On January 28, 2026, a formal inquiry was submitted to the FDA regarding the labeling of Meow Mix Original Choice. The product packaging features high-quality imagery of grilled chicken breast, roasted turkey, and fresh fish fillets. Yet, a review of the ingredient deck reveals a starkly different reality: the product contains chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal.
When pressed for an explanation as to how this complies with the "truthfully labeled" requirement of federal law, the FDA failed to provide a response. A follow-up inquiry sent on March 12, 2026, was similarly ignored. As of September 15, 2026, nearly eight months after the initial request, the agency has yet to justify how an image of fresh, whole-food ingredients can legally represent a product composed of rendered meals.
The Mystery of "Tankage" (July 2026)
The terminology used on pet food labels remains a primary source of confusion for the average consumer. On July 6, 2026, the FDA was asked to clarify the regulatory requirements for "tankage"—a product derived from condemned material in slaughterhouses. Specifically, the inquiry sought to determine whether such material must be identified clearly to the consumer or if it can be masked under generic headings like "chicken meal." The FDA offered no response, leaving a significant gap in consumer understanding regarding the origins of protein sources in pet diets.
The Avian Flu Information Gap (September 2025)
Perhaps the most concerning lapse involves public health. In September 2025, inquiries were directed to the FDA regarding the agency’s messaging on Highly Pathogenic Avian Influenza (HPAI). While the FDA has issued multiple alerts concerning raw pet food, data suggests that only 4% of diagnosed domestic cat cases were linked to raw consumption.
The advocate’s inquiry highlighted a glaring omission: where did the remaining 96% of the cats contract the virus? If those cats consumed kibble or were primarily outdoor animals, the FDA’s singular focus on raw diets could be viewed as a dangerous misdirection of public health resources. By withholding data on the 96%—the primary, unaddressed segment of the affected population—the FDA has arguably hindered the ability of pet owners to protect their animals. The agency declined to answer these critical public health questions.
Bureaucratic Evasion: The AAFCO Modernization Debacle
The FDA’s disconnect with the realities of the market was further highlighted by its handling of the Association of American Feed Control Officials (AAFCO) label modernization efforts. After the FDA formally ended its long-standing memorandum of understanding with AAFCO, confusion ensued regarding the future of pet food labeling standards.
When asked on May 29, 2025, whether the FDA intended to implement the pending AAFCO label updates, the agency responded with a link to a generic press release that contained no mention of the modernization project. A follow-up request for a direct answer resulted in the same circular response: "We would refer you to our previous response." This interaction underscores a growing trend within the agency: the use of "deflection by reference" to avoid committing to specific regulatory stances or future policy implementations.
A Legacy of Delay: The Citizen Petition Struggle
The current state of affairs is not a recent development but the culmination of years of institutional inertia. In 2022, a formal Citizen Petition was filed, outlining multiple instances of misleading labeling and requesting that the FDA fulfill its statutory obligations. Federal law dictates that the agency must respond to such petitions within 180 days. Instead, the FDA took 1,333 days—nearly four years—to provide a response, which was ultimately a rejection of the request for enforcement.
On April 13, 2026, a Petition for Reconsideration was filed, providing additional evidence of widespread consumer deception. The petitioner requested a response within 45 days. As of September 15, 2026, 155 days have passed, and the FDA has remained silent.
Implications for Public Health and Consumer Trust
The implications of this regulatory silence are profound. When a federal agency charged with protecting the food supply refuses to engage in dialogue, it creates a vacuum of accountability.
1. Erosion of Market Integrity
The "truthful labeling" requirement is not merely an aesthetic concern; it is a vital safeguard. If manufacturers can use imagery that bears no resemblance to the actual chemical composition of the food, the market loses the incentive to provide quality ingredients. When the regulator allows this, the consumer loses the ability to make informed decisions about their pets’ nutrition.
2. Public Health Risks
The handling of the Avian Flu data is perhaps the most critical failure. By focusing exclusively on raw pet food while potentially ignoring the risks associated with dry kibble or environmental exposure, the FDA may be creating a false sense of security for millions of pet owners. Public health policy must be based on complete, transparent data, not selective disclosures that support a specific, pre-existing narrative.
3. The Future of Oversight
The breakdown in the relationship between the FDA and industry observers suggests that the current oversight model is failing. The transition away from AAFCO, combined with the agency’s refusal to answer basic questions about labeling, suggests a period of regulatory instability. Without a clear path toward transparency, stakeholders are left to navigate a marketplace where the "rules of the game" are increasingly opaque.
Conclusion: The Call for Accountability
The persistent refusal of the FDA to answer legitimate, fact-based questions is a disservice to the American public. As the pet food industry continues to grow in complexity and reach, the need for a vigilant, communicative regulator has never been greater.
The strategy of the FDA—to delay, deflect, and ignore—does not serve the interests of pet health or public trust. As long as the agency remains silent, organizations like TruthaboutPetFood.com and the Association for Truth in Pet Food serve as the only line of defense for the consumer. Until the FDA chooses to align its actions with the transparency it claims to uphold, pet owners are left with a simple, albeit frustrating reality: the responsibility for safety and truth remains, primarily, in their own hands.
The quest for answers continues. For pet owners, the lesson is clear: in an environment where regulatory oversight is compromised by silence, informed vigilance is the only way to ensure the safety of the animals in their care.
